ANTONELLI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 7.970
EU - Europa 3.463
AS - Asia 3.335
SA - Sud America 632
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 65
OC - Oceania 13
Totale 15.674
Nazione #
US - Stati Uniti d'America 7.765
CN - Cina 1.153
SG - Singapore 1.146
DE - Germania 907
UA - Ucraina 568
PL - Polonia 566
BR - Brasile 534
HK - Hong Kong 309
IT - Italia 276
FI - Finlandia 239
RU - Federazione Russa 231
VN - Vietnam 211
FR - Francia 204
GB - Regno Unito 185
TR - Turchia 143
CA - Canada 109
IN - India 101
IE - Irlanda 99
BD - Bangladesh 97
MX - Messico 42
BE - Belgio 39
AR - Argentina 28
ZA - Sudafrica 25
SE - Svezia 22
NL - Olanda 21
CZ - Repubblica Ceca 20
ES - Italia 20
IR - Iran 20
IQ - Iraq 18
JP - Giappone 18
EC - Ecuador 16
SA - Arabia Saudita 15
CO - Colombia 14
ID - Indonesia 13
AU - Australia 12
PK - Pakistan 12
AE - Emirati Arabi Uniti 11
MA - Marocco 10
UZ - Uzbekistan 10
VE - Venezuela 10
AT - Austria 8
EU - Europa 8
JM - Giamaica 8
MY - Malesia 8
UY - Uruguay 8
CL - Cile 7
CR - Costa Rica 7
LT - Lituania 7
NG - Nigeria 7
RO - Romania 7
AZ - Azerbaigian 6
BO - Bolivia 6
GT - Guatemala 6
PT - Portogallo 6
HU - Ungheria 5
IL - Israele 5
KE - Kenya 5
KR - Corea 5
KZ - Kazakistan 5
NI - Nicaragua 5
NP - Nepal 5
PY - Paraguay 5
SV - El Salvador 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
EG - Egitto 4
JO - Giordania 4
LV - Lettonia 4
MK - Macedonia 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
ET - Etiopia 3
GP - Guadalupe 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
MD - Moldavia 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
TH - Thailandia 3
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GR - Grecia 2
NO - Norvegia 2
PH - Filippine 2
SY - Repubblica araba siriana 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
IS - Islanda 1
KH - Cambogia 1
Totale 15.474
Città #
Ashburn 865
Fairfield 780
Singapore 580
Woodbridge 577
Warsaw 563
Jacksonville 448
San Jose 408
Houston 379
Seattle 313
Hong Kong 308
Ann Arbor 294
Cambridge 290
Beijing 288
Wilmington 256
Chandler 244
The Dalles 208
Princeton 191
New York 188
Council Bluffs 182
Helsinki 153
Los Angeles 133
Munich 117
Istanbul 108
Nanjing 103
Dublin 99
Lauterbourg 94
Dearborn 77
Nürnberg 59
Dallas 58
Ho Chi Minh City 58
São Paulo 53
Brescia 51
Turku 51
Buffalo 48
Jinan 48
Nanchang 48
Des Moines 47
Shanghai 46
Shenyang 44
Moscow 41
Redondo Beach 41
Santa Clara 41
Columbus 37
Brussels 36
Changsha 33
Milan 32
Hanoi 31
San Diego 31
Orem 30
San Francisco 29
Dong Ket 28
Toronto 28
Chicago 27
Frankfurt am Main 27
Hebei 27
Rio de Janeiro 26
Montreal 25
London 24
San Mateo 24
Tianjin 24
North Bergen 23
Washington 23
Jiaxing 22
Monmouth Junction 22
Phoenix 22
Denver 21
Guangzhou 20
Johannesburg 19
Chennai 18
Rome 18
Tokyo 18
Ardabil 17
Atlanta 17
Falkenstein 17
Hangzhou 17
Boston 15
Da Nang 15
Düsseldorf 15
Leawood 15
Zhengzhou 15
Kunming 14
Lancaster 14
Verona 14
Brooklyn 13
Hefei 13
Manchester 13
Mexico City 13
Augusta 12
Charlotte 12
Stockholm 12
Boardman 11
Brasília 11
Lanzhou 11
Orange 11
Poplar 11
Amsterdam 10
Brno 10
Campinas 10
Paris 10
Curitiba 9
Totale 10.102
Nome #
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 287
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 286
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 282
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 259
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 253
Pros-IT CNR: an Italian prostate cancer monitoring project 230
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 224
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 194
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 194
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 191
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 185
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 183
External histopathological validation of the surface-intermediate-base margin score 183
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 182
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 182
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 181
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 180
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 180
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 177
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 175
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 175
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 175
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 175
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 174
Serum vitamin D and prostate cancer prognosis: The story continues 174
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 173
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 172
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 169
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 168
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 167
PERIOPERATIVE MORBIDITY OF CLAMP VERSUS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 166
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 166
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 165
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 164
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 163
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 162
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. 160
RALP CAN REDUCE THE RATE OF POSITIVE SURGICAL MARGIN: COMPARISON WITH OPEN PROSTATECTOMY IN A MEDIUM VOLUME CENTER 156
The occurrence of intraoperative complications during partial nephrectomy and their impact on postoperative outcome: results from the RECORd1 project 154
The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm3): analysis of a cohort of 210 consecutive patients with low-risk disease. 153
The Percentage of Core Involved by Cancer Is the Best Predictor of Insignificant Prostate Cancer, According to an Updated Definition (Tumor Volume up to 2.5 cm(3)): Analysis of a Cohort of 210 Consecutive Patients With Low-risk Disease 152
Positive surgical margins and early oncological outcomes of robotic versus open radical prostatectomy at a medium case-load institution 152
NEPHRON SPARING SURGERY DOES NOT DECREASE OTHER-CAUSES MORTALITY RELATIVE TO RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 150
IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY 150
PIV-03 NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 150
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 150
Prognostic role of tumour multifocality in renal cell carcinoma. 149
Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration 148
OUTCOMES OF PREVENTIVE VS. DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: A RANDOMIZED TRIAL 148
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 144
Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. 143
Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function 143
PROSPECTIVE ANALYSIS OF COMPLICATIONS AND THEIR PREDICTIVE FACTORS AFTER PARTIAL NEPHRECTOMY IN A MULTICENTER COMPARATIVE ITALIAN STUDY (RECORD1) 143
Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project) 143
NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG-TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS 141
RENAL FUNCTION IMPAIRMENT AFTER NEPHRON SPARING SURGERY OR RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 141
Clinical features and prognosis of patients with renal cancer and a second malignancy 141
MANAGEMENT AND PROGNOSIS OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY: RETROSPECTIVE ANALYSIS OF A CONTEMPORARY COHORT 140
OUTCOMES OF A PHASE II I RANDOMIZED CONTROLLED TRIAL COMPARING PREVENTIVE VERSUS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY 139
Surgical treatment of atypical metastasis from renal cell carcinoma (RCC). 139
HOW LONG SHOULD THE FOLLOW-UP BE EXTENDED AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW-UP 138
Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: Perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). 136
TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: Results from a large multicenter dataset 135
PERIOPERATIVE COMPLICATIONS AFTER PARTIAL NEPHRECTOMY FOR COMPLEX (PADUA SCORE >= 10) RENAL TUMORS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD2 PROJECT) 134
PERIOPERATIVE MORBIDITY OF CLAMP VS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 134
HEAD-TO-HEAD EXTERNAL VALIDATION OF RENAL, PADUA, ABC SCORES AND C-INDEX IN NEPHRON SPARING SURGERY 132
WIDESPREAD PIN CAN PREDICT THE DIAGNOSIS OF PROSTATE CANCER AFTER A FIRST NEGATIVE RE-BIOPSY 130
ROBOT-ASSISTED PARTIAL NEPHRECTOMYAND BILATERAL PYELOLYTHOTOMY OF ECTOPIC PELVIC KIDNEYS 129
Cardiopulmonary bypass with brain perfusion for renal cell carcinoma with caval thrombosis 129
Renal Cancer Follow-up Counterpoint: Europe 128
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 128
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 126
Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project). 125
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 124
On-clamp versus off-clamp robotic partial nephrectomy: A systematic review and meta-analysis 124
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 123
CHEST FOLLOW-UP SCHEDULE OF SURGICALLY RESECTED RENAL CELL CARCINOMA SHOULD BE DIFFERENTIATED ACCORDING TO HISTOLOGICAL SUBTYPE 122
Role of Clinical and Surgical Factors for the Prediction of Immediate, Early and Late Functional Results, and its Relationship with Cardiovascular Outcome after Partial Nephrectomy: Results from the Prospective Multicenter RECORd 1 Project 122
ROBOT-ASSISTED RADICAL PROSTATECTOMY: LEARNING-CURVE AND CONTINENCE RATES 122
END STAGE RENAL DISEASE AFTER SURGERY IN PATIENTS WITH NORMAL PREOPERATIVE KIDNEY FUNCTION: THE EFFECT OF NEPHRON-SPARING SURGERY IN DELAYING THE ONSET OF THE DISEASE 122
External Validation of the Arterial-Based Complexity Score and First Head-to-Head Comparison With the R.E.N.A.L. and PADUA Scores and C-index 121
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 119
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 116
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy 114
IMPACT OF GENDER IN NEPHRON-SPARING SURGERY: COMPARISON OF PERIOPERATIVE AND PATHOLOGICAL OUTCOMES FROM THE DEFINITIVE RESULTS OF RECORD1 PROJECT 112
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 109
Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal carcinoma. 109
NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 109
POSITIVE SURGICAL MARGINS PREDICT PROGRESSION-FREE SURVIVAL AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: RESULTS FROM A SINGLE CENTRE COHORT OF ALMOST 500 CASES WITH A MINIMUM FOLLOW_UP OF 5 YEARS 107
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 106
PD49-06 THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE THE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 105
A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study 101
Tumour contact surface area as a predictor of postoperative complications and renal function in patients undergoing partial nephrectomy for renal tumours 100
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis 98
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 96
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: "Midsummer Night's Dream" or "Much Ado About Nothing"? 95
Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial 90
THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 89
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review 85
A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 85
Totale 15.074
Categoria #
all - tutte 72.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022561 0 0 0 22 14 44 29 50 47 96 56 203
2022/2023688 100 14 37 43 71 182 0 62 98 4 42 35
2023/2024976 51 19 72 100 58 229 24 48 203 26 9 137
2024/20251.907 13 14 10 272 179 170 148 81 200 153 410 257
2025/20263.835 384 489 280 568 484 252 498 158 176 326 140 80
2026/2027905 107 154 235 409 0 0 0 0 0 0 0 0
Totale 15.674